FDA questions data for J&J ovarian cancer drug

Courtesy Newsvine - business  Mon, 07/13/2009 - 08:20

Food and Drug Administration scientists are questioning whether study results are reliable enough to warrant approval for a new cancer drug from Johnson & Johnson.


 

Related items

What's in a cigarette? FDA to study ingredients
The Food and Drug Administration is working to lift the smokescreen clouding the ingredients used in cigarettes and other tobacco products.

Wyeth sues FDA to block rival generic antibiotic
Drugmaker Wyeth is suing the Food and Drug Administration to block the sale of a generic rival to its intravenous antibiotic Zosyn, claiming the generic is not an equivalent product and could...

FDA approves new HIV test from Abbott Laboratories
The Food and Drug Administration has approved a new test from Abbott Laboratories that detects both types of the virus that causes AIDS.

AT&T 5800 Accessory Handset for 5800 Series Phones
Advanced American Telephones designs and produces the telephone products that millions of people enjoy every day. AT&T's voice quality, product selection, and reliability make these telephone...

Iris USOA447 IRIScan Express 2 Portable Scanner
Scan Anywhere. Get Organized! The IRIScan Express 2 is ultra portable, and backed by a powerful software suite, so you can get things done! Scan your documents, receipts, business cards,...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
CAPTCHA
We apologize for the inconvenience. Please help fight spam.
business.marc8.com